Akero Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -262.63 M

Akero Therapeutics, Inc. Free Cash Flow is USD -262.63 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 68.49% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
  • Akero Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -155.88 M, a 65.34% change year over year.
  • Akero Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -94.27 M, a 11.95% change year over year.
  • Akero Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -84.21 M, a 7.99% change year over year.
  • Akero Therapeutics, Inc. Free Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -77.98 M.
Key Data
Date Free Cash Flow Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities